Otoferlin is a prognostic biomarker in patients with clear cell renal cell carcinoma: A systematic expression analysis.

Alexander CoxYuri TolkachJohannes SteinGlen KristiansenManuel RitterJörg Ellinger

Published in: International journal of urology : official journal of the Japanese Urological Association (2021)

Our data suggest otoferlin as an indicator of tumor aggressiveness and as a prognostic biomarker for patients with clear cell renal cell carcinoma, leading to the conclusion that otoferlin could promote the malignancy of clear cell renal cell carcinoma.

Keyphrases

electronic health record
artificial intelligence
deep learning